Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : GlaxoSmithKline Biologicals
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
Safety and reactogenicity of a booster dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ vaccine in healthy Vietnamese children
To assess the safety and reactogenicity of the study vaccine in terms of solicited symptoms, unsolicited symptoms and serious adverse events (SAEs).
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
A study to evaluate persistence of hepatitis B antibodies, immunogenicity and safety of Engerix™-B Kinder challenge dose, in adolescents vaccinated with four doses of Infanrix™ hexa during infancy
To assess the immunological response to hepatitis B antigen, in terms of antibody concentrations ≥100 mIU/ml, one month after the single challenge dose of the HBV vaccine in subjects 14-15 years of ag...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
A phase I/II, randomized, single blind, controlled study in adults aged 18-60 years to evaluate the immunogenicity, safety and reactogenicity of an adjuvanted influenza vaccine candidate (GSK 2115160A)
•To assess the immunological non- inferiority (GMT) of the quadrivalent influenza study vaccine over the trivalent influenza vaccine for the three recommended interpandemic strains. •To assess the imm...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
A phase IIIb randomized, open, controlled study to assess the effect of prophylactic antipyretic treatment on the rate of febrile reactions following concomitant administration of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal conjugate vaccine with GSK Biologicals’ Infanrix hexa vaccine in children at 3, 4 and 5 months of age and GSK Biologicals’ Rotarix vaccine at 3 and 4 months of age
To determine the percentage reduction in febrile reactions (rectal temperature > or = 38.0°C) when prophylactic antipyretic treatment is administered compared to no prophylactic antipyretic treatment,...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals - GSK China Vaccines
MAJ Il y a 5 ans
Immunogenicity and reactogenicity study of GlaxoSmithKline Biologicals’ Infanrix™/Hib vaccine administered as a booster dose to 18-24 months old children
To evaluate the immune response to all vaccine antigens, i.e. diphtheria and tetanus toxoids, pertussis toxoid (PT), filamentous haemagglutinin (FHA), pertactin (PRN), and polyribosyl-ribitol-phosphat...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
Safety of Hib-MenCY-TT vaccine versus licensed Hib conjugate vaccine, given at 2, 4, 6 and 12 to 15 months of age
Occurrence of SAEs from dose 1 up to Day 30 after dose 3 and from Dose 1 up to the day preceding the fourth dose. Occurrence of specific adverse events of new onset of chronic illness(es), rash, and ...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
An open, phase I/II study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ 11PCV combined with adjuvant AS02V given as a 2-dose vaccination in adults aged 18-40 years old
• To assess in healthy adult subjects the safety and reactogenicity of the 11PCV adjuvanted with AS02V, given as a 2-dose vaccination 3 months apart. • To evaluate the B-cell memory response to 11 pol...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
A phase III, multicentric open study to evaluate the immunological memory induced by a 3-dose primary vaccination followed by a booster dose with GSK Biologicals’ 11-valent conjugate pneumococcal vaccine compared to unprimed subjects by giving a single dose of Aventis Pasteur’s 23-valent pneumococcal polysaccharide vaccine (Pneumo 23)
To assess the immune memory induced by the full four dose vaccination schedule with GSK Biologicals’ 11-valent pneumococcal vaccine compared to unprimed subjects by giving a single dose of Aventis Pas...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
Study to evaluate immunogenicity and safety of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine at 9 and 10 years after vaccine administration and assessment of re-vaccination with 2 additional doses at 10 years after initial vaccination, in healthy subjects aged 60 years of age and older
• To evaluate persistence of humoral and cell mediated immune responses overall at Months 108 and 120 post first dose of initial vaccination course in study Zoster-003 (NCT00434577).
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
GlaxoSmithKline Biologicals
MAJ Il y a 5 ans
Study to evaluate efficacy, safety, reactogenicity and immunogenicity study of the lyophilised formulation of human rotavirus (HRV) vaccine 444563 in healthy Japanese infants
To determine if two doses of the lyophilised formulation of GSK Biologicals’ HRV vaccine can prevent any RV GE leading to a medical intervention and caused by the circulating wild-type RV strains duri...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations
Précédent
15
16
17
18
19
20
21
22
23
24
Suivant